Rejection: The French Competition Authority rejects the referral of four radiotherapists who complained that they had been denied access to the technical platform of a radiotherapy centre in Essonne for lack of sufficient evidence (CRRO)

KEYWORDS
Reference

Fr. Comp. Auth., Dec. 19th, 2022, dec. n° 22-D-25 on practices in the radiotherapy sector

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. On December 19, 2022, the French Competition Authority issued a decision n° 22-D-25 In this decision, it dismissed the complaint filed by four doctors practicing radiotherapy and benefiting from access to the technical platform of the Ris-Orangis Radiotherapy Center (CRRO), under the terms of the agreement signed with this center, who complained that they had been forced out of the center in

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

This document is protected by copyright laws and international copyright treaties. Non-authorised use of this document constitutes a violation of the publisher's rights and may be punished by up to 3 years imprisonment and up to a € 300 000 fine (Art. L 335-2 Code de la Propriété Intellectuelle). Personal use of this document is authorised within the limits of Art. L 122-5 CPI and DRM protection.

PDF Version

Author

  • L’actu-concurrence (Paris)
    France 4538 contributions 1120571 visits

Quotation

Alain Ronzano, Rejection: The French Competition Authority rejects the referral of four radiotherapists who complained that they had been denied access to the technical platform of a radiotherapy centre in Essonne for lack of sufficient evidence (CRRO), 19 December 2022, Concurrences N° 1-2023, Art. N° 110659, www.concurrences.com

Visites 72

All reviews